(Q70871971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

K L Rost

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

J Brockmöller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

F Esdorn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

I Roots

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

268-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Omeprazole: effects on oxidative drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Comparative tolerability profile of omeprazole in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Oral pharmacokinetics of omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Variability in individual response to various doses of omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Pharmacokinetic study of omeprazole in elderly healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Assessment of liver metabolic function. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2895%2980005-0

7 January 2021

10.1016/S0168-8278(95)80005-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8550990%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference